Reference health
First FDA Approval Agnostic of Cancer Site — When a Biomarker Defines the Indication
5/5 checkable references clean · checked 2026-07-23
Every reference with a DOI in the deposited reference list resolved to a known work in Crossref or DataCite at the dated check, and none carried a retraction, withdrawal, or removal notice.
The 5 checked references that resolve
resolves10.1038/nm.4191
Classification and characterization of microsatellite instability across 18 cancer types
resolves10.1158/1078-0432.CCR-14-0332
Mismatch Repair Status and
<i>BRAF</i>
Mutation Status in Metastatic Colorectal Cancer Patients: A Pooled Analysis of the CAIRO, CAIRO2, COIN, and FOCUS Studies
resolves10.1200/JCO.2015.63.2497
Phase II Pilot Study of Vemurafenib in Patients With Metastatic
<i>BRAF</i>
-Mutated Colorectal Cancer
resolves10.1158/1538-7445.SABCS16-PD2-08
Abstract PD2-08: Neratinib + fulvestrant in <i>ERBB2</i>-mutant, HER2–non-amplified, estrogen receptor (ER)-positive, metastatic breast cancer (MBC): Preliminary analysis from the phase II SUMMIT trial
What this badge says. CiteStamped means the CHECKABLE references of this
work were clean at the dated check: each resolved to a known work in a public registry, and none
carried a retraction notice at that time. It says nothing about the quality, findings,
or importance of the work itself, and nothing about references deposited without a DOI.
checked 2026-07-23 — re-checked daily as this page is visited; titles and statuses come from Crossref and DataCite and are not part of the signed record
Embed this badge
Both snippets point at the live badge image and link back to this page. The badge re-renders from the daily check, so an embed never goes stale by more than a day of visits.
<a href="https://citestamp.com/citestamped/10.1056/nejmp1709968"><img src="https://citestamp.com/citestamped/10.1056/nejmp1709968/badge.svg" alt="CiteStamped reference-health badge" width="460" height="64"></a>
[](https://citestamp.com/citestamped/10.1056/nejmp1709968)